BRAF and neoplasm: Multidisciplinary therapy composing of mainstream modality for glioma revolved around the second surgery, radiation, chemotherapy and molecular therapy using BRAF V600E inhibitor, was placed on her, resulted in stable regression of the tumor for more than 2 years so far.